Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | MMP2 | P08253 | 3/20 | 0.55 |
| ▸ | MMP9 | P14780 | 3/20 | 0.55 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.55 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.55 |
| ▸ | CPB1 | P15086 | 1/20 | 0.54 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.54 |
| ▸ | MMP1 | P03956 | 1/20 | 0.53 |
| ▸ | MMP3 | P08254 | 1/20 | 0.53 |
| ▸ | MMP7 | P09237 | 1/20 | 0.53 |
| ▸ | MMP13 | P45452 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24038542 | 1.00 | FOLH1 (0.66) | FOLH1LMNASMN1; SMN2MMP2MMP9 | |
| SCHEMBL25597725 | 0.92 | LMNA (0.57) | FOLH1LMNASMN1; SMN2SIRT2SIRT1 | |
| SCHEMBL25260928 | 0.90 | FOLH1 (0.59) | FOLH1LMNASMN1; SMN2SIRT2CPB1 | |
| SCHEMBL24038748 | 0.89 | KLK7 (0.55) | FOLH1LMNASMN1; SMN2 | |
| SCHEMBL29214548 | 0.89 | KLK7 (0.55) | FOLH1LMNASMN1; SMN2 | |
| SCHEMBL29072085 | 0.88 | FOLH1 (0.76) | FOLH1MMP2MMP9SIRT2SIRT1 | |
| SCHEMBL29072081 | 0.88 | FOLH1 (0.76) | FOLH1MMP2MMP9SIRT2SIRT1 | |
| SCHEMBL30823334 | 0.88 | FOLH1 (0.64) | FOLH1LMNASMN1; SMN2MMP2MMP9 | |
| SCHEMBL23451327 | 0.87 | FOLH1 (0.57) | FOLH1LMNASMN1; SMN2SIRT2SIRT1 | |
| SCHEMBL23451328 | 0.87 | FOLH1 (0.57) | FOLH1LMNASMN1; SMN2SIRT2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115516044-B | Fluorescent dimer compounds useful as probes for detection of endogenous receptors | 斯特拉斯堡大学 | 2024-05-14 | — | — | CN | disclosed |
| US-20230174480-A1 | FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS | UNIVERSITE DE STRASBOURG (FR) | 2023-06-08 | — | — | US | disclosed |
| US-20230174480-A1 | FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS | UNIVERSITE DE STRASBOURG (FR) | 2023-06-08 | — | — | US | disclosed |
| EP-4150009-A1 | FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS | Université de Strasbourg (FR) | 2023-03-22 | — | — | EP | disclosed |
| WO-2021228939-A1 | FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS | UNIVERSITE DE STRASBOURG (FR) | 2021-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174480-A1 | FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS | GPR3, GPR174, GPR139 | FOLH1 554/4885LMNA 4464/4885SMN1; SMN2 4882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.